Dublin, Nov. 04, 2019 (GLOBE NEWSWIRE) -- The "Global Bioelectric Medicine Market: Focus on Product, 11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2025" report has been added to ResearchAndMarkets.com's offering.

The global bioelectric medicine industry analysis projects the market to grow at a significant CAGR of 6.41% during the forecast period, 2019-2025. The bioelectric medicine market generated $18,636.4 million revenue in 2018.

The bioelectric medicine growth has been primarily attributed to the major drivers such as growing geriatric population leads to surge in exigency of bioelectric medicine, increasing burden of diseases inciting the use of bioelectric medicine, growing investments and funds for the development of novel therapeutics and electroceuticals, limited success rate of drugs targeting specific disease, increasing amount of adverse drug reaction, and upsurge in awareness level.

The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include growth in emerging countries and technological advancement in bioelectric medicine. However, there are significant challenges which are restraining the market growth. These challenges include product recall, exorbitant cost of electroceuticals, increased regulatory scrutiny, and complications and side effects associated with the bioelectric medicine devices.

Expert Quote

The pacemaker represents the biggest opportunity in the bioelectric medicine market, as the demand of pacemaker and awareness of about the pacemakers are higher compare to other bioelectric medicine products. The upsurge prevalence of cardiovascular diseases and the growing geriatric population has made it the largest sources of bioelectric medicine for the treatment of cardiovascular disorders.

Scope of the Market

The bioelectric medicine market research provides a holistic view of the market in terms of various factors influencing it, regulatory reforms, and technological advancements. The scope of this report is centered upon a detailed study of the products, associated with the market.

In addition, the study also includes exhaustive information on the market needs, details on the new products, competitive landscape, market share of leading players, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global bioelectric medicine market.

Market Segmentation

• The bioelectric medicine market segmentation (on the basis of product type) is further segmented into implantable and non-implantable.
• On the basis of implantable bioelectric medicine, the bioelectric medicine market is segmented into pacemaker, ICDs, spinal cord stimulation devices, cochlear implant, deep brain stimulation device, vagus nerve stimulation device, and others.
  

Key Companies

The key manufacturers that have been contributing significantly to the bioelectric medicine market include Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, electroCore, Inspire Medical Systems, LivaNova, Medtronic, Nevro Corp, Nuvectra Corporation, NeuroMetrix, Omron Corporation, Pixium Vision, Second Sight Medical Products, Biotronik & Co, MED-EL, SetPoint Medical, and Stimwave, among others.

Key Questions Answered in this Report

• What are the different types of bioelectric medicine available in the market and what are the benefits offered by them?
• What are the major drivers, challenges, and opportunities in the global bioelectric medicine market?
• What are the key development strategies implemented by the key players to stand out in this market?
• What are the leading companies dominating the global bioelectric medicine market?
• How many types of bioelectric medicine are available in the market, and which are the companies offering them?
• Based on product type, which bioelectric medicine is anticipated to witness a massive rise in demand in the forecast period?
• What are the perceptions of the investors about the global bioelectric medicine market?
• What are the regulations pertaining to the global bioelectric medicine market? What are the initiatives implemented by different government bodies regulating the development and commercialization of bioelectric medicine?
• What was the market value in 2018 of the leading segments and sub-segments of the global bioelectric medicine market?
• How is each segment of the global bioelectric medicine market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2025?
• How is the industry anticipated to evolve during the forecast period 2019-2025?
• Which region is expected to contribute to the highest sales of the global bioelectric medicine market during the forecast period?
• What are the leading trends and consumer preferences witnessed in global bioelectric medicine markets?

Key Topics Covered

Executive Summary

1 Product Definition

2 Scope of Work
2.1 Overview: Report Scope
2.2 Segmentation of the Global Bioelectric Medicine Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report:
2.5 Base Year and Forecast Period

3 Research Methodology
3.1 Overview: Research Methodology

4 Industry Analysis
4.1 Regulatory Scenario
4.1.1 Legal Requirements and Regulations
4.1.1.1 Regulations in the U.S.
4.1.1.2 Regulations in Europe
4.1.1.3 Regulations in Other Countries
4.2 Patent Analysis
4.3 Product Pipeline

5 Competitive Landscape
5.1 Overview
5.2 Key Strategies and Development (2016-2019)
5.2.1 Product Launches, Approvals, and Clearances
5.2.2 Joint Venture, Agreement, Collaborations, and Partnerships
5.2.3 Mergers and Acquisitions
5.2.4 Business Expansion
5.3 Market Share Analysis of Spinal Cord Stimulation Devices in the Global Bioelectric Medicine Market
5.4 Market Share Analysis of Cochlear Implant in the Global Bioelectric Medicine Market
5.5 Market Share Analysis of Pacemaker and ICD in the Global Bioelectric Medicine Market
5.6 Growth Share Analysis

6 Evolution of Bioelectric Medicine
6.1 Evolution of the Pacemaker
6.2 Enabling Technologies Evolving Pacemaker and ICD
6.3 Evolution of the Neurostimulation Therapy
6.4 Enabling Technologies Evolving Neurostimulation Therapies

7 Global Bioelectric Medicine Market, 2018-2025
7.1 Assumptions and Limitations
7.2 Global Market Scenario
7.3 Market Dynamics
7.3.1 Overview
7.3.2 Impact Analysis
7.3.3 Market Drivers
7.3.3.1 Growing Geriatric Population Leads to Surge in Exigency of Bioelectric Medicine
7.3.3.2 Increasing Burden of Disease Inciting the Use of Bioelectric Medicine
7.3.3.2.1 Increasing Prevalence of Neurological Disorders
7.3.3.2.2 Increasing Prevalence of Hearing Loss
7.3.3.2.3 Increasing Prevalence of Cardiovascular Disorders
7.3.3.2.4 Increasing Burden of Blindness
7.3.3.3 Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals
7.3.3.4 Limited Success Rate of Drugs Targeting Specific Disease
7.3.3.5 Increasing Amount of Adverse Drug Reaction
7.3.3.6 Upsurge in Awareness Level
7.3.4 Market Restraints
7.3.4.1 Product Recall
7.3.4.2 Exorbitant Cost of Electroceuticals
7.3.4.3 Increased Regulatory Scrutiny
7.3.4.4 Complications and Side-Effects Associated with the Bioelectric Medicine Devices
7.3.5 Market Opportunities
7.3.5.1 Growth in Emerging Countries
7.3.5.2 Technological Advancement in Bioelectric Medicine
7.3.5.2.1 Development of Closed Loop Neuromodulation
7.3.5.2.2 Evolution of Biomarker-Based Therapeutics Enabling Early Diagnostics of Neurological Disorders
7.3.5.2.3 Technological Advancement in Pacemakers
7.3.5.2.4 Technological Advancement in ICDs

8 Global Bioelectric Medicine Market by Product Type, 2018-2025
8.1 Overview
8.2 Competitive Benchmarking
8.3 Implantable Bioelectric Medicine
8.3.1 Cardiac Pacemaker
8.3.2 Implantable Cardioverter Defibrillators (ICD)
8.3.3 Spinal Cord Stimulation Device
8.3.4 Cochlear Implants
8.3.5 Deep Brain Stimulation Device
8.3.6 Vagus Nerve Stimulation Device
8.3.7 Others
8.4 Non-Implantable Bioelectric Medicine

9 Global Bioelectric Medicine Market (by Region)
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Latin America
9.6 Middle East & Africa

10 Company Profiles
10.1 Overview
10.2 Abbott Laboratories
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Role of Abbott Laboratories in the Bioelectric Medicines Market
10.2.4 SWOT Analysis
10.3 Boston Scientific Corporation
10.4 Biotronik SE & Co. KG
10.5 Cochlear Limited
10.6 electroCore Inc.
10.7 Inspire Medical Systems Inc.
10.8 LivaNova PLC
10.9 Medtronic PLC
10.10 MED-EL
10.11 Nevro Corp.
10.12 Nuvectra Corporation
10.13 NeuroMetrix Inc.
10.14 Omron Corporation
10.15 Pixium Vision
10.16 Second Sight Medical Products Inc.
10.17 SetPoint Medical
10.18 Stimwave LLC

For more information about this report visit https://www.researchandmarkets.com/r/dwcse3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.